Search

Keizo Number Koya

from Chestnut Hill, MA
Age ~66
Get Report
Also known as:
Keito Koya, Ruby Roberts
Phone and address:
234 Bonad Rd, Boston, MA 02467
(617) 323-5119
Related to:
Bianca Li, 28Ai Yi Lin, 43
Connected to:
Vijay Koya, 46Vladimir Koya, 35Wale O KoyaHideyuki Koyama, 57Jun Koyama, 55Ken Koyama, 46Monica J Koyama, 53Sachiko Koyama, 80Takeo Koyama, 75Thomas R Koyama, 71

Keizo Koya Phones & Addresses

  • 234 Bonad Rd, Chestnut Hill, MA 02467 (617) 323-5119
  • 805 Heath St, Chestnut Hill, MA 02467
  • 214 Union Wharf, Boston, MA 02109
  • Sudbury, MA
  • Brookline, MA
  • Woburn, MA
  • Lexington, MA
  • 234 Bonad Rd, Chestnut Hill, MA 02467

Work

Company: Synta pharmaceuticals Sep 2002 to Jun 2012 Position: Senior vice president, drug development

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Kyushu University Specialities: Engineering, Organic Chemistry

Skills

Drug Discovery • Pharmaceutical Industry • Pharmacology • Drug Development • Lifesciences • Clinical Development • Clinical Trials • Cro • Immunology • Biopharmaceuticals • Biochemistry • Gmp • R&D • Medicinal Chemistry • Assay Development • Glp • Cancer • Organic Chemistry • Commercialization • Life Sciences • Pharmaceutics • Protein Chemistry

Languages

English • Japanese

Industries

Pharmaceuticals

Resumes

Resumes

Keizo Koya Photo 1

President And Ceo, Founder

View page
Location:
Boston, MA
Industry:
Pharmaceuticals
Work:
Synta Pharmaceuticals Sep 2002 - Jun 2012
Senior Vice President, Drug Development
Strategia Holdings Sep 2002 - Jun 2012
President and Ceo, Founder
Shionogi Bioresearch Corp Sep 1997 - Sep 2002
Vice President, R and D
Fuji Immunopharmaceuticals Sep 1995 - Sep 1997
Director, Drug Discovery and Development
Fujifilm Sep 1993 - Sep 1995
Head, Pharamaceutical R and D
Education:
Kyushu University
Doctorates, Doctor of Philosophy, Engineering, Organic Chemistry
Skills:
Drug Discovery
Pharmaceutical Industry
Pharmacology
Drug Development
Lifesciences
Clinical Development
Clinical Trials
Cro
Immunology
Biopharmaceuticals
Biochemistry
Gmp
R&D
Medicinal Chemistry
Assay Development
Glp
Cancer
Organic Chemistry
Commercialization
Life Sciences
Pharmaceutics
Protein Chemistry
Languages:
English
Japanese

Business Records

Name / Title
Company / Classification
Phones & Addresses
Keizo Koya
Director
BOSTON STRATEGICS THERAPEUTICS CORPORATION
6500 Main St STE 1020N C/O L PARADISO, Houston, TX 77030
234 Bonad Rd, Chestnut Hill, MA 02467
Keizo Koya
Director, President
Strategia Therapeutics, Inc.
Pharmaceuticals
214 Un Wharf, Boston, MA 02109
234 Bonad Rd, Chestnut Hill, MA 02467
Keizo Koya
President, Director, Treasurer
BOSTON STRATEGICS CORPORATION
Commercial Physical Research · Nonclassifiable Establishments
214 Un Wharf, Boston, MA 02109
234 Bonad Rd, Boston, MA 02467
234 Bonad Rd, Chestnut Hill, MA 02467

Publications

Us Patents

Quinone Derivatives

View page
US Patent:
6433199, Aug 13, 2002
Filed:
May 21, 1999
Appl. No.:
09/316190
Inventors:
Mitsunori Ono - Lexington MA
Keizo Koya - Brookline MA
Lijun Sun - Decatur AL
Yumiko Wada - Waltham MA
Wojciech Wrona - Brookline MA
Natalie Dales - Arlington MA
Xueliang Tao - Arlington MA
Sylvia Holden - Woburn MA
Assignee:
Shionogi BioResearch Corporation - Lexington MA
International Classification:
C07D23502
US Classification:
552500, 548516, 5483027
Abstract:
The invention relates to a quinone derivative of the following formula: which is capable of converting into two alkylating agents upon bioreduction. Substituents A, B, C, and D are as described herein.

Water-Soluble Bean-Based Extracts

View page
US Patent:
6458406, Oct 1, 2002
Filed:
Jan 21, 2000
Appl. No.:
09/489059
Inventors:
Mitsunori Ono - Lexington MA, 02420
Keizo Koya - Brookline MA, 02446
Noriaki Tatsuta - Lexington MA, 02420
Naoto Yamaguchi - Lexington MA, 02421
Lan Bo Chen - Lexington MA, 02420
International Classification:
A23L 120
US Classification:
426634, 426629, 426655, 426539, 426594, 426599, 426590, 426 3, 426631
Abstract:
This invention relates to a water-soluble bean-based extract including one or more isoflavone glycosides. Also included is a method of preparing such a water-soluble bean-based extract.

Water-Soluble Soybean Extracts

View page
US Patent:
6541062, Apr 1, 2003
Filed:
Dec 18, 2000
Appl. No.:
09/739067
Inventors:
Mitsunori Ono - Lexington MA, 02420
Keizo Koya - Brookline MA, 02446
Noriaki Tatsuta - Lexington MA, 02420
Naoto Yamaguchi - Lexington MA, 02421
Lan Bo Chen - Lexington MA, 02420
International Classification:
A23L 128
US Classification:
426655, 426431, 426589, 426594, 426597, 426599, 426590, 426 3, 426631, 426634
Abstract:
This invention relates to a water-soluble soybean-based extract including one or more isoflavone glycosides. Also described is a method of preparing such a water-soluble soybean-based extract.

Water-Soluble Bean-Based Extracts

View page
US Patent:
6616959, Sep 9, 2003
Filed:
Nov 13, 2001
Appl. No.:
10/006326
Inventors:
Mitsunori Ono - Lexington MA, 02420
Keizo Koya - Brookline MA, 02446
Noriaki Tatsuta - Lexington MA, 02420
Naoto Yamaguchi - Lexington MA, 02421
Lan Bo Chen - Lexington MA, 02420
International Classification:
A23L 120
US Classification:
426431, 426634, 426629, 426655, 426590
Abstract:
This invention relates to a water-soluble bean-based extract including one or more isoflavone glycosides. Also shown is a method of preparing such a water-soluble bean-based extract.

2-Aroylimidazole Compounds For Treating Cancer

View page
US Patent:
6743919, Jun 1, 2004
Filed:
Aug 29, 2002
Appl. No.:
10/233371
Inventors:
Keizo Koya - Brookline MA
Lijun Sun - Harvard MA
Mitsunori Ono - Lexington MA
David James - Cambridge MA
Weiwen Ying - Ayer MA
Shoujun Chen - Billerica MA
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
C07D47102
US Classification:
546118, 546119, 546121, 546192, 546197, 546198, 548469, 548470, 514321, 514300, 514304, 514299, 514383, 514387, 514396
Abstract:
Disclosed is a compound represented by Structural Formula (I): R is a substituted or unsubstituted 2-imidazolyl group which is optionally fused to a substituted or unsubstituted aryl group. Z is O, S, NOR , or NR. R is represented by a Structural Formula selected from (II)-(VII): The variables in Structural Formulas (II)-(VII) are described below.

Taxol Enhancer Compounds

View page
US Patent:
6762204, Jul 13, 2004
Filed:
Jul 10, 2002
Appl. No.:
10/193639
Inventors:
Keizo Koya - Brookline MA
Lijun Sun - Harvard MA
Shoujun Chen - Billerica MA
Noriaki Tatsuta - Lexington MA
Yaming Wu - Lexington MA
Mitsunori Ono - Lexington MA
Zhi-Qiang Xia - Dedham MA
Assignee:
Synta Pharmaceuticals, Inc. - Lexington MA
International Classification:
A61K 3116
US Classification:
514599, 564148, 564149, 564151
Abstract:
One embodiment of the present invention is a compound represented by the Structural Formula (I): Y is a covalent bond of a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both C Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or âC(R R )â. R is an aliphatic group, a substituted aliphatic group, a non-aromatic heterocyclic group, or a substituted non-aromatic heterocyclic group, R -R are independently âH, an aliphatic group, a substituted aliphatic group, a non-aromatic heterocyclic group, a substituted non-aromatic heterocyclic group, an aryl group or a substituted aryl group, or R and R taken together with the carbon and nitrogen atoms to which they are bonded, and/or R and R taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. R -R are independently âH, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R and R are each independently âH, an aliphatic or substituted aliphatic group, or R is âH and R is a substituted or unsubstituted aryl group, or, R and R , taken together, are a C2-C6 substituted or unsubstituted alkylene group.

Taxol Enhancer Compounds

View page
US Patent:
6800660, Oct 5, 2004
Filed:
Jul 10, 2002
Appl. No.:
10/193075
Inventors:
Keizo Koya - Brookline MA
Lijun Sun - Harvard MA
Shoujun Chen - Billerica MA
Noriaki Tatsuta - Lexington MA
Yaming Wu - Lexington MA
Mitsunori Ono - Lexington MA
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 3116
US Classification:
514614, 514615, 564148, 564149
Abstract:
Disclosed is a compound represented by the Structural Formula (I): Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both C Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or âC(R R )â. R and R are independently an aryl group or a substituted aryl group, R and R are independently âH, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R -R are independently âH, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R and R are each independently âH, an aliphatic or substituted aliphatic group, or R is âH and R is a substituted or unsubstituted aryl group, or, R and R , taken together, are a C2-C6 substituted or unsubstituted alkylene group. Z is O or S. Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent.

Synthesis Of Taxol Enhancers

View page
US Patent:
6825235, Nov 30, 2004
Filed:
Jul 10, 2002
Appl. No.:
10/193076
Inventors:
Shoujun Chen - Billerica MA
Lijun Sun - Harvard MA
Zhi-Qiang Xia - Dedham MA
Keizo Koya - Brookline MA
Mitsunori Ono - Lexington MA
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 3116
US Classification:
514599, 564148, 564149, 564151
Abstract:
Disclosed is a method of preparing a thiohydrazide product compound from a hydrazide starting compound. The hydrazide starting compound is represented by Structural Formula (I): The thiohydrazide product compound is represented by Structural Formula (II): In Structural Formulas (I)-(II), R and R are independently an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group, or R and R taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. When R is an aryl group or a substituted aryl group, then R is a hydrazine protecting group; and when R is an aliphatic or substituted aliphatic group, then R is âH or a hydrazine protecting group. R is âH or a substituted or unsubstituted alkyl group. The method comprising the step of reacting the starting compound with a thionylating reagent.
Control profile
Keizo Number Koya from Chestnut Hill, MA, age ~66 Get Report